153 related articles for article (PubMed ID: 6803307)
1. Increased platelet activity after termination of prostacyclin infusion into man.
Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E.
Karpen CW; Merola AJ; Trewyn RW; Cornwell DG; Panganamala RV
Prostaglandins; 1981 Oct; 22(4):651-61. PubMed ID: 6798639
[TBL] [Abstract][Full Text] [Related]
3. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
Mehta J; Mehta P; Hay D
Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
[TBL] [Abstract][Full Text] [Related]
4. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
[TBL] [Abstract][Full Text] [Related]
5. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
Grodzińska L; Marcinkiewicz E
Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
[No Abstract] [Full Text] [Related]
6. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
[TBL] [Abstract][Full Text] [Related]
7. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
[TBL] [Abstract][Full Text] [Related]
9. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
10. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
Pan IQ; Hall ER; Wu KK
Br J Haematol; 1984 Oct; 58(2):317-23. PubMed ID: 6089860
[TBL] [Abstract][Full Text] [Related]
11. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
Maurin N
Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
[TBL] [Abstract][Full Text] [Related]
12. Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans.
Dembińska-Kieć A; Kostka-Trabka E; Zumda A; Byrska-Danek A; Bierón K; Grodzińska L; Kedzior A; Zelazny T
Pharmacol Res Commun; 1982 Jun; 14(6):485-98. PubMed ID: 6750655
[No Abstract] [Full Text] [Related]
13. Some properties of mouse platelets.
Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
[TBL] [Abstract][Full Text] [Related]
14. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
[No Abstract] [Full Text] [Related]
15. The use of prostacyclin in the separation from plasma and washing of human platelets.
Vargas JR; Radomski M; Moncada S
Prostaglandins; 1982 Jun; 23(6):929-45. PubMed ID: 6812168
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
17. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
[No Abstract] [Full Text] [Related]
18. Ethanol inhibits platelet thromboxane A2 production but has no effect on lung prostacyclin synthesis in humans.
Toivanen J; Ylikorkala O; Viinikka L
Thromb Res; 1984 Jan; 33(1):1-8. PubMed ID: 6364450
[TBL] [Abstract][Full Text] [Related]
19. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
20. Experimental atherosclerosis in rabbits: platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin.
Zmuda A; Dembinska-Kiec A; Chytkowski A; Gryglewski RJ
Prostaglandins; 1977; 14(6):1035-42. PubMed ID: 341225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
